What are the differences between Crohn's disease and ulcerative colitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Distinguishing Crohn's Disease from Ulcerative Colitis

Crohn's disease and ulcerative colitis are distinct inflammatory bowel diseases that differ fundamentally in anatomical distribution, depth of inflammation, and complications—differences that directly impact treatment decisions and prognosis. 1

Anatomical Distribution

Ulcerative colitis begins in the rectum and extends proximally in a continuous, uninterrupted pattern, affecting only the colon with gradually decreasing severity of inflammation moving proximally. 1, 2 Rectal involvement is present in over 97% of untreated UC cases. 3

Crohn's disease demonstrates patchy, discontinuous inflammation with skip lesions and can affect any part of the gastrointestinal tract from mouth to anus. 1, 2 The terminal ileum is the most commonly affected site. 1 Rectal sparing occurs commonly in CD but is rare in UC (only up to 3% of cases), making this a key distinguishing feature. 1, 3

Depth of Inflammation

The single most critical pathophysiologic difference is the depth of tissue involvement:

  • Ulcerative colitis inflammation is limited to the mucosa and occasionally the submucosa only. 1, 2, 4
  • Crohn's disease exhibits transmural inflammation extending through all layers of the intestinal wall (mucosa, submucosa, muscularis propria, and serosa). 1, 2, 4

This transmural nature in CD drives the development of stricturing and penetrating complications including fistulas, which are hallmark features of Crohn's disease. 1 Approximately one-quarter of perianal fistulas in CD present at or before diagnosis. 1

Histological Features

Granulomas are absent in UC but present in CD, serving as a key distinguishing microscopic feature. 1, 2 When present, non-caseating granulomas are pathognomonic for Crohn's disease. 1

Additional microscopic differences include:

  • Crypt abscesses are more common in UC (41%) than in CD (19%). 2, 3
  • Inflammatory pattern: UC shows diffuse inflammation without variations in intensity, while CD shows focal inflammation that varies in intensity within and between biopsies. 1, 2
  • Mucin depletion is pronounced in UC but uncommon and mild in CD. 1, 2
  • Fissures are characteristically absent in UC but present in CD. 2

Complications

Fistulas represent a hallmark complication of Crohn's disease due to transmural inflammation, allowing penetration through the bowel wall to adjacent structures or skin. 1 Perianal fistulas and ulcers are common in CD but rare in UC. 4

Strictures differ mechanistically: In UC, strictures result from mucosal/submucosal fibrosis only, whereas CD strictures involve all layers of the bowel wall. 1, 2

Colorectal cancer risk is increased in both conditions, but the risk appears equivalent in Crohn's colitis and UC when matched for extent and duration of colonic involvement. 1 However, cancer is historically more common in UC due to more extensive colonic involvement. 4

Diagnostic Approach

Perform complete ileocolonoscopy with at least two biopsies from five different sites (including ileum and rectum, even from normal-appearing areas) to differentiate CD from UC. 1, 3 This is imperative even if initial sigmoidoscopy suggests UC. 3

Systematically complete with cross-sectional imaging (MRI or CT enterography) to evaluate small intestine involvement, as about one-third of CD patients have small intestine disease not detectable by colonoscopy. 1, 3

Obtain basic laboratory assessment including complete blood count, CRP, albumin, liver function tests, iron status, renal function, and vitamin B12. 3

Fecal calprotectin has 93% sensitivity and 96% specificity for diagnosing IBD in adults, with an optimal threshold of 100 μg/g. 3

Common Pitfalls

In 5-15% of IBD cases, endoscopic and histological evaluation cannot distinguish between CD and UC (termed indeterminate colitis or IBD-unclassified). 2, 3, 5 In these cases, capsule endoscopy can establish a definitive CD diagnosis by demonstrating small intestine lesions in 17-70% of patients. 1, 3

Exclude infectious causes before finalizing diagnosis, as infections (particularly Clostridioides difficile and cytomegalovirus) can mimic IBD. 3, 5 Testing for C. difficile toxin is mandatory when an IBD flare is suspected. 3

Medical treatment can alter typical patterns: Therapy can modify the continuous inflammation pattern in UC, potentially inducing discontinuous inflammation reminiscent of CD. 5 In cases of diagnostic doubt, review original biopsies to ascertain the diagnosis. 5

Recognize that UC is not "cured" by colectomy: Postoperative complications, especially pouchitis and fecal incontinence, affect more than one-third of patients after surgery. 6 While total colectomy removes the diseased colon, it does not eliminate all disease burden. 6

References

Guideline

Key Differences Between Crohn's Disease and Ulcerative Colitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Pathophysiological Differences Between Ulcerative Colitis and Crohn's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach for Crohn's Disease versus Ulcerative Colitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Ulcerative Colitis and Crohn's Disease Have Similar Burden and Goals for Treatment.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.